FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2066475375> ?p ?o ?g. }

• W2066475375 endingPage "2139" @default.
• W2066475375 startingPage "2139" @default.
• W2066475375 abstract "Paclitaxel attenuates renal interstitial fibroblast activation and interstitial fibrosis by inhibiting STAT3 signaling Lei Zhang,1,2,* Xuan Xu,1,* Ruhao Yang,1,* Jingwen Chen,1 Shixuan Wang,5 Junqin Yang,3 Xudong Xiang,1 Zhibiao He,1 Yu Zhao,4 Zheng Dong,2,5 Dongshan Zhang11Department of Emergency Medicine, 2Department of Nephrology, 3Department of Minimally Invasive Surgery, Second Xiangya Hospital, Central South University, Changsha, Hunan, People’s Republic of China; 4Department of Nephrology, Harbin First Hospital, Harbin, Heilongjiang, People’s Republic of China; 5Department of Cellular Biology and Anatomy, Medical College of Georgia at Georgia Regents University and Charlie Norwood VA Medical Center, Augusta, GA, USA *Co-first authors in this studyAbstract: Recent studies have demonstrated that paclitaxel might inhibit renal fibrosis. However, the underlying molecular mechanism remains unclear. In this study, we hypothesized that low-dose paclitaxel may block the STAT3 (signal transducer and activator of transcription 3) signaling to attenuate fibrosis in a mouse model with unilateral ureteral obstruction. Both NRK-49F cells and mice with unilateral ureteral obstruction were treated with paclitaxel. The results showed that paclitaxel treatment resulted in a dose- and time-dependent decrease in tyrosine-phosphorylated STAT3, and inhibited the expression of fibronectin, alpha-smooth muscle actin (α-SMA), and collagen I in cultured NRK-49F cells. S3I-201, an STAT3 inhibitor, also suppressed the expression of fibronectin, α-SMA, and collagen I in cultured NRK-49F cells. Mechanistically, paclitaxel treatment blocked the STAT3 activity by disrupting the association of STAT3 with tubulin and inhibiting STAT3 nucleus translocation. Furthermore, paclitaxel also ameliorated renal fibrosis by down-regulating the expression of fibronectin, α-SMA, and collagen I, and suppressed the infiltration of macrophages and production of TNF-α, IL-1β, TGF-β, and ICAM-1 (intercellular adhesion molecule 1) by inhibition of STAT3 activity in obstructive nephropathy. These results suggest that paclitaxel may block the STAT3 activity by disrupting the association of STAT3 with tubulin and inhibiting STAT3 nucleus translocation, consequently leading to the suppression of renal interstitial fibroblast activation and the development of renal fibrosis, and inhibition of proinflammatory cytokine production.Keywords: UUO, tubulointerstitial fibrosis, tubulin, paclitaxel, STAT3" @default.
• W2066475375 created "2016-06-24" @default.
• W2066475375 creator A5000195058 @default.
• W2066475375 creator A5022876276 @default.
• W2066475375 creator A5041695225 @default.
• W2066475375 creator A5050155862 @default.
• W2066475375 creator A5055518755 @default.
• W2066475375 creator A5065524262 @default.
• W2066475375 creator A5071798264 @default.
• W2066475375 creator A5083708018 @default.
• W2066475375 creator A5084611031 @default.
• W2066475375 creator A5088443080 @default.
• W2066475375 creator A5091450644 @default.
• W2066475375 date "2015-04-01" @default.
• W2066475375 modified "2023-09-28" @default.
• W2066475375 title "Paclitaxel attenuates renal interstitial fibroblast activation and interstitial fibrosis by inhibiting STAT3 signaling" @default.
• W2066475375 cites W1566750909 @default.
• W2066475375 cites W1921614063 @default.
• W2066475375 cites W1969630360 @default.
• W2066475375 cites W1975857636 @default.
• W2066475375 cites W1980325398 @default.
• W2066475375 cites W1984943896 @default.
• W2066475375 cites W1995049975 @default.
• W2066475375 cites W2007840001 @default.
• W2066475375 cites W2013959979 @default.
• W2066475375 cites W2014763555 @default.
• W2066475375 cites W2021644664 @default.
• W2066475375 cites W2043900785 @default.
• W2066475375 cites W2049533449 @default.
• W2066475375 cites W2051910047 @default.
• W2066475375 cites W2052399749 @default.
• W2066475375 cites W2053352604 @default.
• W2066475375 cites W2059466576 @default.
• W2066475375 cites W2059559292 @default.
• W2066475375 cites W2065659252 @default.
• W2066475375 cites W2067027564 @default.
• W2066475375 cites W2068949553 @default.
• W2066475375 cites W2069982090 @default.
• W2066475375 cites W2083162753 @default.
• W2066475375 cites W2091310109 @default.
• W2066475375 cites W2101539899 @default.
• W2066475375 cites W2104899786 @default.
• W2066475375 cites W2114338375 @default.
• W2066475375 cites W2121860798 @default.
• W2066475375 cites W2144143559 @default.
• W2066475375 cites W2153602227 @default.
• W2066475375 cites W2155357669 @default.
• W2066475375 cites W2317298663 @default.
• W2066475375 doi "https://doi.org/10.2147/dddt.s81390" @default.
• W2066475375 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4404961" @default.
• W2066475375 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25931810" @default.
• W2066475375 hasPublicationYear "2015" @default.
• W2066475375 type Work @default.
• W2066475375 sameAs 2066475375 @default.
• W2066475375 citedByCount "60" @default.
• W2066475375 countsByYear W20664753752015 @default.
• W2066475375 countsByYear W20664753752016 @default.
• W2066475375 countsByYear W20664753752017 @default.
• W2066475375 countsByYear W20664753752018 @default.
• W2066475375 countsByYear W20664753752019 @default.
• W2066475375 countsByYear W20664753752020 @default.
• W2066475375 countsByYear W20664753752021 @default.
• W2066475375 countsByYear W20664753752022 @default.
• W2066475375 countsByYear W20664753752023 @default.
• W2066475375 crossrefType "journal-article" @default.
• W2066475375 hasAuthorship W2066475375A5000195058 @default.
• W2066475375 hasAuthorship W2066475375A5022876276 @default.
• W2066475375 hasAuthorship W2066475375A5041695225 @default.
• W2066475375 hasAuthorship W2066475375A5050155862 @default.
• W2066475375 hasAuthorship W2066475375A5055518755 @default.
• W2066475375 hasAuthorship W2066475375A5065524262 @default.
• W2066475375 hasAuthorship W2066475375A5071798264 @default.
• W2066475375 hasAuthorship W2066475375A5083708018 @default.
• W2066475375 hasAuthorship W2066475375A5084611031 @default.
• W2066475375 hasAuthorship W2066475375A5088443080 @default.
• W2066475375 hasAuthorship W2066475375A5091450644 @default.
• W2066475375 hasBestOaLocation W20664753751 @default.
• W2066475375 hasConcept C126322002 @default.
• W2066475375 hasConcept C1491633281 @default.
• W2066475375 hasConcept C185592680 @default.
• W2066475375 hasConcept C2776694085 @default.
• W2066475375 hasConcept C2777292972 @default.
• W2066475375 hasConcept C2778923194 @default.
• W2066475375 hasConcept C2780559512 @default.
• W2066475375 hasConcept C502942594 @default.
• W2066475375 hasConcept C54847362 @default.
• W2066475375 hasConcept C55493867 @default.
• W2066475375 hasConcept C62478195 @default.
• W2066475375 hasConcept C71924100 @default.
• W2066475375 hasConcept C86492073 @default.
• W2066475375 hasConcept C86803240 @default.
• W2066475375 hasConcept C95444343 @default.
• W2066475375 hasConcept C98274493 @default.
• W2066475375 hasConceptScore W2066475375C126322002 @default.
• W2066475375 hasConceptScore W2066475375C1491633281 @default.
• W2066475375 hasConceptScore W2066475375C185592680 @default.
• W2066475375 hasConceptScore W2066475375C2776694085 @default.
• W2066475375 hasConceptScore W2066475375C2777292972 @default.

• next